NO20044098L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20044098L
NO20044098L NO20044098A NO20044098A NO20044098L NO 20044098 L NO20044098 L NO 20044098L NO 20044098 A NO20044098 A NO 20044098A NO 20044098 A NO20044098 A NO 20044098A NO 20044098 L NO20044098 L NO 20044098L
Authority
NO
Norway
Prior art keywords
new connections
connections
new
Prior art date
Application number
NO20044098A
Other languages
English (en)
Norwegian (no)
Inventor
Xiao-Qing Lewell
Lee Andrew Harrison
Suzanne Elaine Keeling
Stephen Swanson
Rachael Anne Ancliff
Caroline Mary Cook
Colin David Eldred
Paul Martin Gore
Simon Tennby Hodgson
Duncan Bruce Judd
Graeme Michael Robertson
Martin Alistair Hayes
Gail Mills
Andrew John Walker
Mark Wilkinson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20044098L publication Critical patent/NO20044098L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20044098A 2002-03-28 2004-09-27 Nye forbindelser NO20044098L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0207449.0A GB0207449D0 (en) 2002-03-28 2002-03-28 Novel compounds
PCT/EP2003/003339 WO2003082291A1 (en) 2002-03-28 2003-03-27 N-{´ (2s) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions

Publications (1)

Publication Number Publication Date
NO20044098L true NO20044098L (no) 2004-10-04

Family

ID=9933998

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044098A NO20044098L (no) 2002-03-28 2004-09-27 Nye forbindelser

Country Status (22)

Country Link
US (1) US20060058299A1 (enExample)
EP (1) EP1487453B1 (enExample)
JP (1) JP4490110B2 (enExample)
KR (1) KR20040095347A (enExample)
CN (1) CN1642553A (enExample)
AR (1) AR039177A1 (enExample)
AT (1) ATE454892T1 (enExample)
AU (1) AU2003216905A1 (enExample)
BR (1) BR0308719A (enExample)
CA (1) CA2479910A1 (enExample)
DE (1) DE60330952D1 (enExample)
ES (1) ES2339436T3 (enExample)
GB (1) GB0207449D0 (enExample)
IL (1) IL163648A0 (enExample)
IS (1) IS7415A (enExample)
MX (1) MXPA04009458A (enExample)
NO (1) NO20044098L (enExample)
PL (1) PL372930A1 (enExample)
RU (1) RU2004126145A (enExample)
TW (1) TW200400823A (enExample)
WO (1) WO2003082291A1 (enExample)
ZA (1) ZA200406990B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275257A1 (en) 2002-09-26 2004-04-19 Bristol-Myers Squibb Company N-substituted heterocyclic amines as modulators of chemokine receptor activity
JP2009501792A (ja) * 2005-07-21 2009-01-22 アストラゼネカ・アクチエボラーグ ケモカイン受容体のモジュレーターとしてのｎ−ベンジル−モルホリン誘導体
HUP0500886A2 (en) * 2005-09-23 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use
HUP0500877A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
CA2623317A1 (en) * 2005-09-22 2007-03-29 Sanofi-Aventis Amino-alkyl-amide derivatives as ccr3 receptor liquids
HUP0800478A2 (en) * 2008-07-31 2010-03-01 Sanofi Aventis Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands
CN104203231A (zh) * 2011-12-01 2014-12-10 葛兰素集团有限公司 治疗和预防眼疾病的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS562929A (en) * 1979-06-21 1981-01-13 Sumitomo Chem Co Ltd Preparation of optically active cyclopentenolone
US4870074A (en) * 1986-04-30 1989-09-26 Dainippon Pharmaceutical Co., Ltd. Substituted benzamide derivatives, for enhancing gastrointestinal motility
JPH01117882A (ja) * 1987-10-30 1989-05-10 Dainippon Pharmaceut Co Ltd 複素環式カルボン酸アミド誘導体
JPH03291274A (ja) * 1990-04-09 1991-12-20 Yoshitomi Pharmaceut Ind Ltd アミノアルキルモルホリン誘導体の製造法
JPH04270272A (ja) * 1991-02-25 1992-09-25 Yoshitomi Pharmaceut Ind Ltd アミノアルキルモルホリン誘導体の製造法
TW223629B (enExample) * 1992-03-06 1994-05-11 Hoffmann La Roche
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
US6031097A (en) * 1997-10-27 2000-02-29 Neurogen Corporation 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands
EP1140834A1 (en) * 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Heterocyclic piperidines as modulators of chemokine receptor activity
CA2383327C (en) * 1999-09-14 2009-11-03 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
BR0114323A (pt) * 2000-09-29 2003-07-01 Glaxo Group Ltd Composto ou um seu sal ou solvato farmaceuticamente aceitável, composição farmacêutica, uso do composto ou de um seu sal ou solvato farmaceuticamente aceitável, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar o composto
BR0114321A (pt) * 2000-09-29 2003-07-01 Glaxo Group Ltd Composto, composição farmacêutica, uso de um composto, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar um composto

Also Published As

Publication number Publication date
CA2479910A1 (en) 2003-10-09
JP2005525390A (ja) 2005-08-25
ATE454892T1 (de) 2010-01-15
ES2339436T3 (es) 2010-05-20
AU2003216905A1 (en) 2003-10-13
CN1642553A (zh) 2005-07-20
IS7415A (is) 2004-08-19
EP1487453A1 (en) 2004-12-22
MXPA04009458A (es) 2005-07-27
KR20040095347A (ko) 2004-11-12
IL163648A0 (en) 2005-12-18
BR0308719A (pt) 2005-01-04
TW200400823A (en) 2004-01-16
DE60330952D1 (de) 2010-03-04
GB0207449D0 (en) 2002-05-08
EP1487453B1 (en) 2010-01-13
WO2003082291A1 (en) 2003-10-09
PL372930A1 (en) 2005-08-08
AR039177A1 (es) 2005-02-09
US20060058299A1 (en) 2006-03-16
RU2004126145A (ru) 2005-06-27
JP4490110B2 (ja) 2010-06-23
ZA200406990B (en) 2005-11-08

Similar Documents

Publication Publication Date Title
NO20044588L (no) Nye forbindelser
NO20044432L (no) Nye forbindelser
NO20055219D0 (no) Nye forbindelser
NO20040014L (no) Nye forbindelser
NO20041003L (no) Nye forbindelser
NO20034665L (no) Nye forbindelser
NO20035428D0 (no) Nye anti-ineffektiver
NO20034992D0 (no) Nye 4-aninlinokinolin-3-karboksamider
NO20054224D0 (no) Nye 2-pyridinkarboksamidderivater
NO20044046L (no) Substituerte hydroksyetylaminer
NO20034970D0 (no) Nye arylheteroalkylaminderivater
DE50311715D1 (de) Weltzeituhr
DE60333552D1 (de) Münzverarbeitungssystem
DE60332518D1 (de) Strömungswegumschaltventil
NO20043595L (no) Nye kortikosteroider
DK1513861T3 (da) Etonogestrelestere
DE50309536D1 (de) Fadenabsaugvorrichtung
DE60225603D1 (de) Schaltartstromversorgungsstartkreis
NO20041185L (no) Nye sykloheksylsulfoner
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
DE60320809D1 (de) Klemmring
NO20026285D0 (no) Nye peptider
NO20035248D0 (no) Nye fenylalkyloksy-fenyl derivater
NO20044098L (no) Nye forbindelser
DE60236137D1 (de) Gradationsverarbeitungsmethode

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application